The comparison using the parameters of tumor diameter, tumor site, mitotic rate, NIH risk and depth of invasion revealed statistically significant differences between the Ki-67+ and Ki67− groups, though no difference was identified for the CD117 marker. The gene discussed is KIT; the disease is neoplasm.